{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_004833.2:c.6058G>A",
          "cDNA Change": {
            "transcript": "NM_004833.2",
            "ref": "G",
            "alt": "A",
            "position": "6058"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S mutation in LRRK2 associated with Parkinson's disease."
        },
        {
          "HGVS": "NM_004833.2:c.4322G>T",
          "cDNA Change": {
            "transcript": "NM_004833.2",
            "ref": "G",
            "alt": "T",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C mutation in LRRK2 associated with Parkinson's disease."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005146"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunoblotting",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Lentiviral transduction of SH-SY5Y cells with LRRK2-G2019S construct."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004833.2:c.6058G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased LRRK2 kinase activity and α-synuclein accumulation in G2019S-expressing cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 construct used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "LRRK2 kinase activity within 20% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "LRRK2 kinase activity exceeding 150% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "CRISPR/Cas9",
      "Material used": {
        "Material Source": "Animal model",
        "Material Name": "Zebrafish",
        "Description": "CRISPR/Cas9-generated LRRK2-G2019S zebrafish model."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_004833.2:c.6058G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2-G2019S zebrafish exhibited locomotor deficits and increased α-synuclein aggregation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "No explicit mention of replicates."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "No explicit mention of replicates."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "No explicit mention of controls."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No explicit mention of controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not specified."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal locomotor behavior and no α-synuclein aggregation.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced locomotor activity and detectable α-synuclein aggregation.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    },
    {
      "Assay Method": "Drosophila model",
      "Material used": {
        "Material Source": "Animal model",
        "Material Name": "Drosophila melanogaster",
        "Description": "LRRK2-R1441C transgenic Drosophila model."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_004833.2:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2-R1441C flies exhibited neurodegeneration and reduced lifespan."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "No explicit mention of replicates."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "No explicit mention of replicates."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "No explicit mention of controls."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No explicit mention of controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not specified."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal neuronal morphology and lifespan.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Neuronal degeneration and 30% reduction in lifespan.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    }
  ]
}